45 related articles for article (PubMed ID: 11205199)
1. HPV testing: where are we now?
Bovicelli A; Bristow RE; Montz FJ
Anticancer Res; 2000; 20(6C):4673-80. PubMed ID: 11205199
[TBL] [Abstract][Full Text] [Related]
2. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
[TBL] [Abstract][Full Text] [Related]
3. Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses.
Arbyn M; Sasieni P; Meijer CJ; Clavel C; Koliopoulos G; Dillner J
Vaccine; 2006 Aug; 24 Suppl 3():S3/78-89. PubMed ID: 16950021
[TBL] [Abstract][Full Text] [Related]
4. Predicting absolute risk of CIN3 during post-colposcopic follow-up: results from the ASCUS-LSIL Triage Study (ALTS).
Walker JL; Wang SS; Schiffman M; Solomon D;
Am J Obstet Gynecol; 2006 Aug; 195(2):341-8. PubMed ID: 16890545
[TBL] [Abstract][Full Text] [Related]
5. High-risk human papillomavirus DNA testing: a marker for atypical glandular cells.
Saqi A; Gupta PK; Erroll M; Babiac A; Blackmun D; Mansukhani M; Vazquez M
Diagn Cytopathol; 2006 Mar; 34(3):235-9. PubMed ID: 16470857
[TBL] [Abstract][Full Text] [Related]
6. HPV DNA testing of the residual sample of liquid-based Pap test: utility as a quality assurance monitor.
Zuna RE; Moore W; Dunn ST
Mod Pathol; 2001 Mar; 14(3):147-51. PubMed ID: 11266518
[TBL] [Abstract][Full Text] [Related]
7. [Integrating HPV testing for primary screening?].
Riethmuller D; Ramanah R; Pretet JL; Mougin C
J Gynecol Obstet Biol Reprod (Paris); 2008 Feb; 37 Suppl 1():S139-51. PubMed ID: 18191912
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of combining testing for p16 protein and human papillomavirus (HPV) in cervical carcinoma screening.
Ekalaksananan T; Pientong C; Sriamporn S; Kongyingyoes B; Pengsa P; Kleebkaow P; Kritpetcharat O; Parkin DM
Gynecol Oncol; 2006 Oct; 103(1):62-6. PubMed ID: 16494930
[TBL] [Abstract][Full Text] [Related]
9. HPV DNA testing in the triage of atypical squamous cells of undetermined significance (ASCUS): cost comparison of two methods.
Layfield LJ; Qureshi MN
Diagn Cytopathol; 2005 Aug; 33(2):138-43. PubMed ID: 16007672
[TBL] [Abstract][Full Text] [Related]
10. Elevated levels of tetraploid cervical cells in human papillomavirus-positive Papanicolaou smears diagnosed as atypical squamous cells of undetermined significance.
Olaharski AJ; Eastmond DA
Cancer; 2004 Jun; 102(3):192-9. PubMed ID: 15211479
[TBL] [Abstract][Full Text] [Related]
11. Performance of a semiautomated Papanicolaou smear screening system: results of a population-based study conducted in Guanacaste, Costa Rica.
Sherman ME; Schiffman M; Herrero R; Kelly D; Bratti C; Mango LJ; Alfaro M; Hutchinson ML; Mena F; Hildesheim A; Morales J; Greenberg MD; Balmaceda I; Lorincz AT
Cancer; 1998 Oct; 84(5):273-80. PubMed ID: 9801201
[TBL] [Abstract][Full Text] [Related]
12. Comparative evaluation of smear cytology & hybrid capture II for the diagnosis of cervical cancer.
Kumar K; Iyer VK; Bhatla N; Kriplani A; Verma K
Indian J Med Res; 2007 Jul; 126(1):39-44. PubMed ID: 17890822
[TBL] [Abstract][Full Text] [Related]
13. Anal Pap smears: Should we be doing them?
Lindsey K; DeCristofaro C; James J
J Am Acad Nurse Pract; 2009 Aug; 21(8):437-43. PubMed ID: 19689440
[TBL] [Abstract][Full Text] [Related]
14. [Efficient cytologic screening: selective and in combination with HPV test].
Rubinstein E
Lakartidningen; 2000 Jan; 97(4):371. PubMed ID: 10684236
[No Abstract] [Full Text] [Related]
15. Hybrid Capture method for detection of human papillomavirus DNA in clinical specimens: a tool for clinical management of equivocal Pap smears and for population screening.
Lörincz AT
J Obstet Gynaecol Res; 1996 Dec; 22(6):629-36. PubMed ID: 9037955
[TBL] [Abstract][Full Text] [Related]
16. Obstetrics and Gynecology Clinics of North America. HPV, colposcopy, and prevention of squamous anogenital tract malignancy. Foreword.
Rayburn WF
Obstet Gynecol Clin North Am; 2013 Jun; 40(2):xiii-xiv. PubMed ID: 23732039
[No Abstract] [Full Text] [Related]
17. Randomized controlled trials of HPV testing and Pap cytology: toward evidence-based cervical cancer prevention.
Franco EL
Int J Cancer; 2004 May; 110(1):1-2. PubMed ID: 15054862
[No Abstract] [Full Text] [Related]
18. [Role of the PAP smear in adolescence].
Jacot-Guillarmod M; Hohlfeld P; Renteria SC
Rev Med Suisse; 2009 Oct; 5(222):2078-80, 2082-4. PubMed ID: 19947449
[TBL] [Abstract][Full Text] [Related]
19. Efficient triage of the "screen-positive" at-risk patient.
Cestero RM; Harer WB
Obstet Gynecol Clin North Am; 2002 Dec; 29(4):735-50. PubMed ID: 12509094
[TBL] [Abstract][Full Text] [Related]
20. FDA panel conditionally approves DNA pap test without ACOG support.
Ostrzenski A
J Natl Med Assoc; 2002 Jun; 94(6):418. PubMed ID: 12078919
[No Abstract] [Full Text] [Related]
[Next] [New Search]
